期刊文献+

普卢利沙星片在健康人体的药代动力学

Pharmacokinetics of prulifloxacin tablets in Chinese healthy volunteers
下载PDF
导出
摘要 目的评价国产盐酸普卢利沙星片(第4代喹诺酮类抗生素)在健康人体的药代动力学。方法10名健康志愿者单剂量和多剂量口服国产盐酸普卢利沙星片200mg,用液相色谱-串联质谱法测定血药浓度,用Winnonlin计算药代动力学参数。结果单剂量和多剂量给药后,Cmax分别为(1.39±5.10),(1.67±0.23)mg·L-1;tmax分别为(0.93±0.37),(1.07±0.43)h;t1/2ke分别为(6.74±1.09),(7.26±0.53)h;AUC0-∞分别为(6.64±1.68),(11.82±1.32)mg·h·L-1,多剂量AUC0-τ为(8.68±0.79)mg·h·L-1。结论每日2次,连续口服国产盐酸普卢利沙星片11次后,体内有一定蓄积。 Objective To evaluate the pharmacokinetics of prulifloxacin tablets in Chinese healthy volunteers. Methods Ten healthy volunteers were randomized to orally receive single and multiple dose prulifloxacin tablets (200 mg). The plasma samples were determined by the LC/MS/ MS method. The data were analysised by Winnonlin software. Results The single dose and multiple dose pharmacokinetic parameters were as follows: CmaxWere (1.39 ±5.10) mg · L^-1 and (1.67 ±0.23) mg · L^-1; tmax were (0.93 ±0.37) h and (1.07 ±0.43) h; t1/2ke were (6.74 ± 1.09) h and (7.26 ±0.53) h;AUC0-x were (6.64 ±1.68) ,(11.82 ± 1.32) mg · h · L^-1 The multiple dose AUC0-r was (8.68 ± 0.79) h · mg · L^-1. Conclusion Administration of prulifloxacin tablets twice per day has some accumulation in healthy volunteers 's body .
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2007年第2期101-104,共4页 The Chinese Journal of Clinical Pharmacology
关键词 普卢利沙星片 药代动力学 液相色谱-串联质谱 pmlifloxacin tablet pharmacokinetics LC/MS/MS
  • 相关文献

参考文献6

  • 1方利明,金艳,魏敏吉.氟喹诺酮类抗菌剂——普卢利沙星[J].中国医药导刊,2004,6(3):225-227. 被引量:20
  • 2Okuyama Y, Momota K, Morino A. Pharmacokinetics of prulifloxacin.2nd communication : pharmacokinetics and effect on hepatic drug - metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats[ J]. Arzneimittelforschung, 1997 ;47:285 -292. 被引量:1
  • 3Okuyama Y, Morino A. Pharmacokinetics of prulifloxacin. 3rd communication : metabolism in rats, dogs and monkeys [ J ]. Arzneimittelforschung, 1997 ;47 : 293 - 298. 被引量:1
  • 4Picollo R, Brion N, Gualano V, et al. Pharmacokinetics and tolerability of prulifloxacin after single oral administration[ J]. Arzneimittelforschung, 2003 ;53:201 -205. 被引量:1
  • 5Takuji Y, Susumu M. Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolne[ J]. Antimicrob Agents Chemother,1993 ;37:793 - 800. 被引量:1
  • 6Nakashima M, Uematus T, Kosuge K, et al. Pharmacokinetics and safety of NM441, a new quinolne , in healthy male volunteers[ J]. J Clin Pharmacol, 1994 ;34 : 930 - 937. 被引量:1

二级参考文献18

  • 1王金生,宋慈媛.新氟喹诺酮抗菌药NM441[J].国外医药(抗生素分册),1996,17(3):224-226. 被引量:11
  • 2Carlo Grassi, Enrica Salvatori, Maria Teresa Rosignoli, et al. Randomized, double - blind study of prulifioxacin versus ciprofloxacin in patients with Acut Exacerbations of Chronic Bronchitis. Respiration,2002; 69: 217~222 被引量:1
  • 3Maria Pia Montanari, Marina Mingoia, Pietro Emanuele Varaldo. In vitro antibacterial activities of AF3013, the actice metabolite of prulifloxacin, against nosocomial and community Italian isolates. Antimicrob Agents Chemother, 2001; 45(12): 3616~ 3622 被引量:1
  • 4Yoshio Okuyama, Kazuo Momota, Akira Morino. Pharmacokinetics of prudifloxacin 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single admiustration. Arzneim. Forsch./Drug Res, 1997; 47(Ⅰ): 276~ 284 被引量:1
  • 5Kura K, Fukui H, Fukui T, et al. General pharmacological studies of NM441 (1). Effect on center and peripheral nervous systems, gastrointestinal tract and smooth muscle. Jpn J Chemother, 1996; 44(Suppl.1): 113~ 128 被引量:1
  • 6Masakuni Ozaki, Masato Matsuda, Yoshifumi Tomii, et al. In vivo evaluation of NM441, a new thiazeto - quinoline derivative. Antimicrob Agents Chemother, 1991; 35(12): 2496- 2499 被引量:1
  • 7Katsuhiko Tougou, Akio Nakamura, Shuji Watanabe, et al. Paraoxonase has a major role in the hydrolysis of prulifloxacin(NM441), a prodrug of a new antibacterial agent. Drug Metab Dispos, 1998; 26:355- 359 被引量:1
  • 8vRossella Picollo, Nils Brion, Virginie Gualano, et al. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.Arzneim. - Forsch./Drug Res, 2003; 53(3): 201 - 205 被引量:1
  • 9Masakuni Ozaki, Masato Matsuda, Yoshifumi Tomii, et al. In vitro antibacterial activity of a new quinolne, NM394. Antimicrob Agents Chemother, 1991;35(12): 2490- 2495 被引量:1
  • 10Takuji Yoshida,Susumu Mitsuhashi. Antibacterial activity of NM394,the active form of prodrug NM441, a new quinolone. Antimicrob Agents Chemother, 1993;37(4): 793 - 800 被引量:1

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部